Kiskis, J. Interferon Cytokine Res. 15 Supplls 184, 1995 (abstract). |
Gutterman, PNAS 91:1198, 1994. |
Bocci, Crit Rev. Ther Drug Carrier Syst 9(2):91-133, 1992 (abstract). |
Babiuch, Archivum Immunologiae et Therapiae Experimentalis 41(3-4):213-219, 1993 (abstract only). |
Caban, Archivom Immunologiae et Therapiae Experimentalis 41(3-4) 1993 pp. 229-235 (abstract only). |
Hayden, Frederick G., "Intranasal Interferon .alpha.2 for Prevention of Rhinovirus Infection and Illness", The Journal of Infectious Diseases, vol. 148, No. 3 Sep. 1983. pp. 543-550. |
Hayden et al., "Human Tolerance Histopathologic Effects of Long Term Administration of Intranasal Interferon-.alpha.2", Journal of Infectious Diseases 148:914-921 (1983). |
Hayden et al., "Human Nasal Mucosal Responses to Topically Applied Recombinant Leukocyte A Interferon", Journal of Infectious Diseases 156:64-72 (1987). |
Machida et al., "Absorption of Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) from Rat Nasal Mucosa", Pharmaceutical Research 10:1372-1377 (1993). |
Samo et al., "Efficacy and Tolerance of Intranasally Applied Recombinant Leukocyte A Interferon in Normal Volunteers", Journal of Infectious Diseases 148:535-542 (1983). |
Samo et al., "Intranasally Applied Recombinant Leukocyte A Interferon in Normal Volunteers. II.", Journal of Infectious Diseases 150:181-188 (1984). |
Takeda et al., "Pharmacological Activity of Tablets Containing Recombinant Human Granulocyte . . . ", International Journal of Pharmaceutics 101:89-96 (1994). |
Watanabe et al., "Absorption and Blood Leukocyte Dynamics of Recombinant Human Granulocyte Colony-Stimulating Factor . . . ", International Journal of Pharmaceutics 110:93-97 (1994). |